SARS-CoV-2, ibicurane A&B Antigen Ikomatanyije Kumenya Kit-EU CE

COVID-19, ibicurane A cyangwa ibicurane B bisangiye ibimenyetso bimwe, bigatuma bigorana gutandukanya virusi eshatu zanduye.Isuzuma ritandukanye ryo kuvura neza intego risaba kwipimisha hamwe kugirango hamenyekane virusi (es) zanduye.

Ibikenewe

Gusuzuma neza itandukaniro ni ngombwa kugirango uyobore imiti ikwiye ya virusi.

Nubwo gusangira ibimenyetso bimwe, COVID-19, ibicurane A na Flu B bikenera ubuvuzi butandukanye bwa virusi.Ibicurane birashobora kuvurwa hamwe na neuraminidase inhibitor hamwe na COVID-19 ikabije hamwe na remdesivir / sotrovimab.

Igisubizo cyiza muri virusi imwe ntabwo bivuze ko udafite abandi.Kwandura hamwe byongera ibyago byindwara zikomeye, kubitaro, gupfa kubera ingaruka ziterwa.

Kwipimisha neza ukoresheje ibizamini byinshi ni ngombwa kugirango uyobore imiti ikwiye ya virusi, cyane cyane hamwe n’indwara zishobora kwandura mu gihe cya virusi y’ubuhumekero.

Ibisubizo byacu

Macro & Micro-IkizaminiSARS-CoV-2, ibicurane A&B Antigen Ikomatanyije, itandukanya ibicurane A, ibicurane B na COVID-19 hamwe nibishobora kwandura byinshi mugihe cyindwara zubuhumekero;

Kwipimisha byihuse indwara nyinshi zubuhumekero, harimo SARS-CoV-2, ibicurane A, na ibicurane B hamwe nicyitegererezo kimwe;

Byuzuye ikizamini cyibizamini hamwe nigice kimwe gusa cyo gusaba hamwe nicyitegererezo kimwe gikenewe gutandukanya Covid-19, ibicurane A na ibicurane B;

Intambwe 4 gusa byihuse ibisubizo muminota 15-20 gusa, bigufasha gufata ibyemezo byubuvuzi byihuse.

Ubwoko bwinshi bw'icyitegererezo: Nasopharyngeal, Oropharyngeal cyangwa Amazuru;

Ubushyuhe bwo kubika: 4 -30 ° C;

Shelf Ubuzima: Amezi 24.

Ibintu byinshi nkibitaro, amavuriro, ibigo nderabuzima byabaturage, farumasi, nibindi.

	SARS-CoV-2	Ibicurane A	IbicuraneB.
Ibyiyumvo	94.36%	94.92%	93.79%
Umwihariko	99.81%	99.81%	100.00%
Ukuri	98.31%	98.59%	98,73%